Topics
- Discovery
- Lab
- Preclinical
- Animal studies, toxicity studies
- Preliminary trial
- Patients
- 14-18 months
- Phase I: Early clinical
- 20-100 participants
- 1-2 years
- Phase II: Mid clinical
- 50-300 participants
- 2 years
- Phase III: Late clinical
- 300-3000 participants
- 1-4 years
- Phase IV: Market
- …